Effect of low-dose aspirin therapy on implantation rate in women undergoing in-vitro fertilization cycles

Saudi Medical Journal

Volumn 28, Issue 5, 2007, Pages 732-736

  Moini, Ashraf ^a   Zafarani, Fatemeh ^a   Haddadian, Sedigheh ^a   Ahmadi, Jila ^a   Honar, Hooman ^a   Riazi, Kiarash ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BUSERELIN; CHORIONIC GONADOTROPIN; ESTRADIOL; HUMAN MENOPAUSAL GONADOTROPIN; PLACEBO; PROGESTERONE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; OOCYTE RETRIEVAL; OVARY FOLLICLE; OVARY HYPERSTIMULATION; PREGNANCY OUTCOME; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL; DRUG EFFECT; NIDATION;

ADULT; ASPIRIN; EMBRYO IMPLANTATION; FEMALE; FERTILIZATION IN VITRO; HUMANS;

EID: 34547450590     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Edwards RG, Craft I. Development of assisted conception. Br Med Bull 1990; 46: 565-569.
2. Navot D, Bergh PA, Williams MA, Garrisi GJ, Guzman I, Sandter B, et al. Poor oocyte quality rather than implantation failure as a cause of age-related decline in female fertility. Lancet 1991; 317: 1375-1377.
3. Paulson RJ, Sauer MV, Lobo RA. Embryo implantation Acter human in vitro fertilizatitm: Importarce of endometrial receptivity. Fertil Steril 1990; 53: 870-874.
4. Kadier BD, Price DE, Roussev RG, Coulam CB. Antiphoyholipid antibody prevalence in padients with IVF failure. Am J Reprod Immunol 1996; 35: 388-393.
5. Steer CV, Campbell. S, Tan SL, Crayford T, Mills C, Mason BA, et al. The use of transvaginal color flow imaging after in vitro fertilization to identifying optimum uterine conditions before embryo transfer. Fertil Steril 2: 372-376.
6. Steer CV, Tan SL, Dillon D, Mason BA, Campbell S. Vaginal color Doppler assessment of uterine artery impedance correlates with immunohistochemical markers of endometrial receptivity required for the implantation of an embryo. Fertil Steril 1995;
7. Battaglia C, Artini PG, Giulini S, Salvatori M. Maxia N, Petraglia F, et al., Color Doppler changes and diromboxane production after ovarian stimulation with gonadothropin-releasing hormone agonist. Hum Reprod 1997; 11: 2477-2482.
8. Rubinstein M, Marrazi A, de Fried EP. Low-dose aspirin treatment: improves ovarian responsiveness, uterine and ovarian, responsiveness, uterine and ovarian blood flow velocity, implantation, and pregnancy rates in patients undergoing in vitro fertilization: A prospective, randomized, double-blind placebo-controlled assay. Fertil Steril 1999; 71: 825-829.
9. Gooswamy RK, Steptoe PC, Decreased uterine perfusion artery in spontaneous ovarian cycles. Hum Reprod 1998; 3: 721-716.
10. Sperro L. Mark FA. Clinical Gynecologic endocrinology and infertility. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 294.
11. Gardner KD, Weissnan A, Howles.MC, Shoham Z. Textbook of assisted reproductive techniques. 2nd ed. London: Taylor & Francis; 2004; p. 663.
12. Wada I, Hsu CC, Williams G, Macnamee MC, Brinsden PR. The benefits of low-dose aspirin therapy in women with impaired uterine ferfusion during assisted. Hum Reprod 1994; 9: 1954-1957.
13. Zaidi J, Pittrof R, Shaker A, Kyei-Mensah A, Campbell S, Tan SL. Assessment: Of uterine artery blood flow on the day of human chorionic gonadotropin administration by transvaginal. color Doppler ultrasound in an in vitro fertilization program. Fered Steril 1996; 65: 177-381.
14. Rai. R, Cohen H, Dave M, Regan L. Randomised controlled. trial of aspirin and aspirin plu sheparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies). BMJ 1997; 314: 253-257.
15. Hasegawa I, Yamamoto Y, Suzuki M, Murakawa H, Kurabayashi T, Takakuwa K, et: Al. Prednisolonc plus low-dose aspirin improves the implantation rate in women with autoimmune conditions who are undergoing in vitro fertilization. Arpril Steril 1998; 70: 1044-1049.
16. Wallenburg HC, Rotmans N, Prevention of recurrent idiopathic fetal growth retardation by low-dose aspirin and dipyridamole. Am J Obstet Gynecol 1987; 157: 1230-1235.
17. Jouppila P, Kirkinen P, Koivula A, Ylikorka O, Failure of exogenous prostacyclin to change placental and fetal blood flow in preeclampsia. Am J Obstet Gynecol 1985; 151: 661-665.
18. Tzafettas J, Petropoulos P, Psarra A, Delkos D, Papaloukas C, Giannoulis H, et al. Early antiplatelet and antithrombotic therapy in patients with a history of recurrent miscarriages of known anti unknown actiology, Eur J Obstet Gynecol Reprod Biol 2005; 120: 22-26.
19. Carta G, Iovenitti P, Falciglia K. Recurrent miscarriage associated with antiphospholipid antibodies: Prophylatic treatment with low-dose aspirin anti fish oil derivatives. Clin Exp Obstet Gynecol 2005; 32: 49-51.
20. Stern C, Chamley L, Norris H, Hale L, Raker HW. A randomized, double-blind, placebo-controlled trial of heparin and aspirin for women with in vitro fertilization implantarion failure and antiphospholipid or antinuclear antibodies. Bertil Steril 2003; 80: 376-393.
21. Lok IH, Yip SK, Cheung LP, Yin Leung PH, Haines CJ. Adjuvant low-dose aspirin therapy in poor responders undergoing in vitro fertilazation: A prospective, randomized, double-blind, placebo-controlled trial. Fertil Steril 2004; 81: 556-561.
22. Hurst BS, Bhojwani JT, Marshburn PB, Papadakis MA, Loeb TA, Martthews ML. Low-dose aspirin does not improve ovarian stimulation, endometrial response, or pregnancy rates for in vitro fertilization. Exp Clin Assist Reprod 2005; 2: 8.
23. Pakkila M, Rasanen J, Heinonen S, Tinkanen H, Tuomivaara L, Makikallio K, et al. Low-dose aspirin does not improve ovarian responsiveness or pregnancy rate in IVF anti ICSI patients: A randomized, placebo-controlled double-blind study. Hum Reprod 2005; 20: 2211-2214. Epub 2005 Apt 7.
24. Naaktgeborn N, Van Den Berg-helder A, Blankhart A, Mendels E, Trimbos-kemper T, Waegemakers C. et al. In vitro fertilization at the ledien hospital: Initial experiences. Acta Eur Fertile, 1987; 10: 3.
25. Lopata A, Martin M, Oliva K, Johnston I. Embryonic development and blastocytes implantation following in vitro fertilization and embryo trasfer. Fertil Steril 1982; 38: 682-687.
26. Yovich Jl, Stranger JD, Yovich JM, Tuvik AI. Quality of embryos from in-virro fertilisation. Lancet 1984; 1: 457.
27. Gratizinskas JG, Nysenbaum AM. Failure of human pregnancy after implantation. Ann N Y Acad Sci 1985;. 442: 38-44.
28. Acosta AA, Moon SY, Oehninger S, Muasher SJ, Rosenwaks, Z, Matta, JF. Implantation potential of each pre-embryo in Multiple pregnancies obtained by in vitro fertilization seems to be different. Fertil Steril 1988; 50: 906-911.
29. Boyers S. Fertilization and implantation. Curr Opinion Obstet Gynecol 1999; 1: 45-54.
30. Waldenstrom U, Hellberg D, Nilsson S. Low dose aspirin in a short: regimen, as standard treatment in in vitro fertilization: A randomized, prospective study. Fertil Stefil 2004; 81: 1560-1564.
31. Weckstein LN, Jacobson A, Galen D, Hampton K, Hammel J. Low-dose aspirin for oocyte donation recipients with a thin endometrium: Proxpective, randomized study. Fertil Steril 1997; 68: 927-930.
32. Sher G, Matzner W, Feinman M, Massarani G, Zouves C, Chong P, et al. The selective use of heparin/aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization. Am J Reprod Immunol 1998; 40: 74-82.
33. Sher G, Zouves C, Feinman M, Maassarani G, Matzner W, Chong, R et al. A rational basis for the use of combined heparin/aspirin and IVIG immunotherapy in the treatment of recurrent IVF failure associated with antiphospholipid anitibodies. Am J Reprod Immunol 1998; 39: 391-394.
34. Sher G, Maassarani G, Zouves C. Feinman M, Sohn S, Matzner W, et al. The we of conihined heparin/aspirin and immunoglobulin G therapy in the treatment of in vitro fertilization patients with antithyroid antibodie. Am J Reprod Immunol 1998; 39: 223-225.
35. Sher G, Feinman M, Zouves C, Kuttner G, Maassarani G, Salem R, et al. High fecundity rates following in-vitro fertilization and embryo transger in antiphospholipid antibody seropositive women treated with heparin anti aspirin. Hum Reprod 1994; 9: 2278-2283.
36. Geva E, Amit A, Lerner-Geva L, Yaron Y, Daniel Y, Schwartz T. et al. Prednisone and aspirin improve pregnancy rate in patients with reproductive failure and autoimmune and antibodies: A prospective study. Am J Reprod Immunol 2000; 43: 36-40.
37. Urman B, Mercan R, Alatas C, Balaban B, Isiklar A, Nahoglu A. Low-dose aspirin does not increase implantation rates in patients undergoing intracytoplasmic sperm injection: A prospective randomized study. J Assist Reprod Genet 2000; 17: 586-590.
38. Rock JA, Hurst BS, Clinical significance of prostanoid concentration in women with endometriosis. Prog Clin Biol Res 1990; 323: 61-80. Review.
39. Sirotkin AV, Makarevich AV, Kwon HB, Kotwica J. Involvement or MAP kinase in the mediation of GH action on ovarian granulosa cells. Mol Cell Endocrinol 2003; 205: 193-199.
40. Hanzen C. Prostaglandins and the physiology of human and animal reproduction. J Gynecol Obstet Biol Reprod (Paris) 1984; 13: 351-361.
41. Practice Committee Report. Antiphospholipid antibodies do not affect IVF success. Birmingham, Alabama, USA.: American Society for Reproductive Medicine; 1999, p. 1-3
42. Li DK, Liu L, Odouli R. Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: Population based cohort study. BMJ 2003; 327: 368.
43. Kozer E, Niktar S, Costei A, Baskovic R, Nulman I, Koren G, Aspirin consumption during the first trimester of pregnancy and congenital anomalies: A meta-analysis. Am J Obstet Gynecol 2002; 187: 1623-1630.
44. Centers for Disease Control and Prevention (CDC), Pregnancy-related death associated with heparin and aspirin treatment for infertility, 1996. MMWR Morb Mortal Wkly Rep 1998; 47: 368-371.